Latest Feature Article
Igniting Genomic Literacy in the Classroom
Empowering students to envision themselves as future scientists, innovators, and trailblazers
Feature Articles
Illumina Named One of Singapore’s Best Employers
Continues regional expansion with a focus on employees
In Full Transparency: A Year of CSR at Illumina
Our 2021 CSR Report documents a year of positive impact
Calling for Policies to Support the Rare Disease Community in NZ
Health advocates highlight the urgent need to address challenges faced by people living with a rare disease
Pacing the Pandemic, One Mutation at a Time
The ongoing story of COVID-19 surveillance
Press Releases
In the News
| Date | Publication | Title |
|---|---|---|
| 20-Apr-2021 | Reuters | EU to examine Illumina's $7.1 billion acquisition of Grail on antitrust grounds |
| 14-Apr-2021 | Sky News (Australia) | Genomic sequencing changing rate of vaccine development |
| 10-Apr-2021 | Axios | Illumina CEO on a genomics-forward future |
| 08-Apr-2021 | Reuters | Illumina CEO says GRAIL deal is good for competition |
| 06-Apr-2021 | CNBC Squawk Box | Illumina CEO Francis deSouza on first-quarter results, outlook and more |
Additional Resources
Investor Information
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsPress Contacts
If you are a member of the media:
- Email pr@illumina.com
- Tel. 858.882.6822
If you are not a member of the media, please visit Contact Us.